Information  X 
Enter a valid email address

Assura plc (AGR)


Friday 29 October, 2021

Assura plc

Notice of Interim Results

RNS Number : 6435Q
Assura PLC
29 October 2021

29 October 2021

Assura plc

Notice of Interim Results

Assura plc ("the Company"), the UK's leading primary care property investor and developer can confirm that Interim Results for the six months ended 30 September 2021 will be announced on Thursday 11th November 2021.

A presentation for analysts will be held on that date at 9.00am GMT and details of how to watch this event can be found on our website, or by using the link below.

Webcast link:  

- Ends -


For more information, please contact:

Assura plc
David Purcell, Head of Investor Relations

Tel: 01925 420680
E mail: [email protected]


Gordon Simpson
James Thompson

Tel: 0207 251 3801
Email: [email protected]


Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2021, Assura's property portfolio was valued at £2,453 million.


Further information is available at


*EPRA is a registered trademark of the European Public Real Estate Association.


Assura plc LEI code: 21380026T19N2Y52XF72



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t